Dabrafenib Mesylate
| CAS No. | 1195768-06-9 |
|---|---|
| MDL No. | MFCD20922872 |
| MF | C24H24F3N5O5S3 |
| MW | 615.70 |
| InChI Key | YKGMKSIHIVVYKY-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Dabrafenib mesylate is a methanesulfonate salt formed from equimolar amounts of dabrafenib and methanesulfonic acid. It is used in the treatment of metastatic melanoma and functions as an antineoplastic agent and B-Raf inhibitor.
| CAS No. | 1195768-06-9 |
|---|---|
| Product Name | Dabrafenib Mesylate |
Biological Targets
BRAF
Associated Conditions
thyroid carcinoma·Erdheim-Chester disease·melanoma·glioma·multiple myeloma·
* The information provided here is compiled from public sources and is for reference only.
